Tests acceptance and commitment therapy for young people with sickle cell disease
Tests a group talk therapy for teens and young adults with sickle cell disease.
Key facts
- Who runs it
- Children's Hospital Los Angeles
- Where
- Los Angeles, United StatesSee the site
- Trial code
- Registry title
- Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease
- Status
- Recruiting
- Phase
- Phase 1/2
- People taking part
- 66 people, planned
- Started
- 1 Apr 2025
- Expected to end
- 30 Jun 2029
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- ACT for SCD
- Record updated
- 6 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for young people aged 14 to 21 with Sickle Cell Disease who are willing to join a group therapy program to cope with race-related stress.
- Age
- 14 to 21 years
- Sex
- All sexes can join.
- Disease stage
- Sickle Cell Disease; no particular stage is named.
Main reasons for not taking part
- Prisoners or youth in detention centers
- Cannot understand or speak English
- Does not have Sickle Cell Disease
- Significant risk of suicide or self-injury
- Currently experiencing psychosis, or severe health concerns that would affect taking part
The registry criteria, word for word
Show all 4 criteriaShow less
Other criteria
- Youth Participant Inclusion and Exclusion Criteria The inclusion criteria for study participation are Be an adolescent and/or young adult (age 14-21) who has Sickle Cell Disease Willing to enroll in the ACT group jointly provided by the Division of Adolescent and Young Adult Medicine/Department of Hematology and Oncology Participants can be active, waitlisted, or new patients at CHLA Participants must be able to understand and speak English, as the therapy will only be delivered in English Participants must have an English-speaking parent/guardian Able to provide consent/assent An adolescent or young adult that is pregnant is eligible to participate if consent can be obtained Participants must be developmentally typical Have a stable internet connection (via computer, tablet, or phone) with access to a webcam and a private space to engage in a group therapy sessions; Must consent to audio and video recording of initial interview. Must agree to attend 6 weekly ACT group session Youth participants will be asked to become a member of the CAB. To become a CAB member, the youth participant must consent/assent to participation in the ACT intervention. If a CAB member, they must be willing to engage in CAB interviews and meetings
- The exclusion criteria are:
- Prisoners or youth in detention centers Unable to understand or speak English Does not have SCD Clients who are at significant risk for suicide and self-injury will be excluded due to the intense levels of support required to support these individuals which would interfere with study procedures
- Adolescents with families that require frequent intervention from the Department of Children and Family Services, are currently experiencing psychosis, or have severe health concerns that will impact study participation or attendance will be excluded
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 14 and 21 years old?
Where in United States
- Children's Hospital Los AngelesLos Angeles, United StatesContact: Xzania W Lee, Ph.D.Taking people
About the trial
What the trial wants to find out
The current study seeks to build on previous research that demonstrates the efficacy of Acceptance and Commitment Therapy in combating stigma by investigating the feasibility and acceptability of a protocol to support Black adolescents and young adults in coping with race related stress. The study will consist of a small, purposeful, non-randomized sample (N = 30) of clients enrolled into a 10-session Acceptance and Commitment Therapy group. The group will be offered as part of regular clinical care at the Division of Adolescent and Young Adult Medicine. Three consecutive groups will be run with approximately 8-10 participants in each group over the next year.
The 2 groups in the trial
- Acceptance Commitment TherapyTreatment being tested
This study will use a 10-session ACT protocol to support Black adolescents and young adults in coping with race related stress.
Treatment: ACT for SCD
- Control GroupNo study treatment, for comparison
Waitlist control group that will receive the intervention 3-4 months after the intervention group concludes.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Using Acceptance and Commitment Therapy (ACT) to Promote Mental Health and Transition Readiness in Youth With Sickle Cell Disease: A Community-Based Participatory Action Research (CBPAR) Approach
- Plain-language title
- Tests acceptance and commitment therapy for young people with sickle cell diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05685368, who can take part
- Record updated
- 6 May 2026